Nan Fung Trinity’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.21M Hold
247,765
– – 0.88% 42
2026
Q2
$15M Hold
247,765
– – 1.48% 29
2026
Q1
$14.4M Buy
247,765
+20,800
+9% +$958K 1.58% 26
2025
Q4
$10.2M Buy
226,965
+68,360
+43% +$2.87M 0.81% 48
2025
Q3
$6.37M Hold
158,605
– – 0.64% 48
2025
Q2
$4.96M Buy
+158,605
New +$5.17M 0.59% 47

Other funds holding XENE

Nan Fung Trinity's XENE Position: Q3 2026 in Review

Nan Fung Trinity held its Xenon Pharmaceuticals (XENE) position steady in Q3 2026 at 247,765 shares worth $9.21M. The position accounts for 0.88% of the portfolio, ranked #42.

Nan Fung Trinity first reported a position in XENE in Q2 2025 and has held it in 6 quarters since. The position peaked at $15M in Q2 2026. 288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Nan Fung Trinity held 247,765 shares of Xenon Pharmaceuticals worth $9.21M as of Q3 2026.
  • Nan Fung Trinity left its Xenon Pharmaceuticals share count unchanged in Q3 2026.
  • Xenon Pharmaceuticals made up 0.88% of Nan Fung Trinity's portfolio in Q3 2026, its #42 holding.
  • Nan Fung Trinity first reported a position in Xenon Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • Nan Fung Trinity's Xenon Pharmaceuticals position peaked at $15M in Q2 2026.
  • 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Nan Fung Trinity's 13F filing for Q3 2026, filed 6 Nov 2026.